We are live on
!
Find out more
NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.72B
1-Year Est. Return
106.92%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+106.92%
3 Year Est. Return
+205.04%
5 Year Est. Return
+179.05%
10 Year Est. Return
+1,028.38%
AUM
$404M
AUM Growth
-$193M
(-32%)
Cap. Flow
-$235M
Cap. Flow
% of AUM
-58.22%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
3
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC Therapeutics
PTCT
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$118M |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$102M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.44% |
| 2 | Healthcare | 6.56% |
Similar funds
SIM
FDCP
HR
GAM
PIMG
AFG
FMLI
FTCM
Novo Holdings A/S's Q3 2013 Portfolio in Review
As of Q3 2013, Novo Holdings A/S held 5 positions worth $404M, down 32% from $597M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Novo Holdings A/S withdrew a net $235M in Q3 2013, reducing 3 holdings. Its largest reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $118M.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 95% a quarter earlier, followed by Healthcare.
Against the trend, Novo Holdings A/S opened a new position in PTC Therapeutics worth $11.2M.
- Novo Holdings A/S's largest Q3 2013 buy was PTC Therapeutics: 747,359 shares worth $11.2M.
- Novo Holdings A/S's biggest Q3 2013 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $118M.
- Novo Holdings A/S's ten largest holdings make up 100% of its $404M portfolio in Q3 2013.
- Novo Holdings A/S opened 1 new position and closed 0 in Q3 2013.
- Novo Holdings A/S's portfolio value fell 32% quarter-over-quarter to $404M.
Based on Novo Holdings A/S's 13F filing for Q3 2013, filed 14 Nov 2014.